Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $22.5 in the prior trading day, Staar Surgical Co (NASDAQ: STAA) closed at $22.12, down -1.69%. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 1.9 million shares were traded. STAA stock price reached its highest trading level at $23.25 during the session, while it also had its lowest trading level at $21.95.
Ratios:
Our goal is to gain a better understanding of STAA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 5.21. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on April 21, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $17.
Mizuho Downgraded its Outperform to Neutral on February 12, 2025, whereas the target price for the stock was revised from $45 to $17.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’26 when BROADWOOD PARTNERS, L.P. bought 336,946 shares for $21.62 per share. The transaction valued at 7,284,281 led to the insider holds 15,356,437 shares of the business.
BROADWOOD PARTNERS, L.P. bought 66,467 shares of STAA for $1,462,301 on Jan 07 ’26. The 10% Owner now owns 15,422,904 shares after completing the transaction at $22.00 per share. On Jan 08 ’26, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 3,240 shares for $21.94 each. As a result, the insider paid 71,082 and bolstered with 15,426,144 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1091974912 and an Enterprise Value of 946748992. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.85 while its Price-to-Book (P/B) ratio in mrq is 3.09. Its current Enterprise Value per Revenue stands at 4.106 whereas that against EBITDA is -17.535.
Stock Price History:
The Beta on a monthly basis for STAA is 1.07, which has changed by -0.016014218 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $30.81, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -12.01%, while the 200-Day Moving Average is calculated to be -1.15%.
Shares Statistics:
The stock has traded on average 1.31M shares per day over the past 3-months and 1780850 shares per day over the last 10 days, according to various share statistics. A total of 49.35M shares are outstanding, with a floating share count of 49.34M. Insiders hold about 0.81% of the company’s shares, while institutions hold 108.42% stake in the company. Shares short for STAA as of 1765756800 were 4826529 with a Short Ratio of 3.68, compared to 1763078400 on 3662036. Therefore, it implies a Short% of Shares Outstanding of 4826529 and a Short% of Float of 17.06.
Earnings Estimates
The dynamic stock of Staar Surgical Co (STAA) is currently being evaluated by a team of 5.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.03, with high estimates of $0.13 and low estimates of -$0.21.
Analysts are recommending an EPS of between $0.14 and -$0.06 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.37, with 6.0 analysts recommending between $0.78 and -$0.23.
Revenue Estimates
6 analysts predict $75.54M in revenue. The current quarter. It ranges from a high estimate of $78.3M to a low estimate of $72.98M. As of. The current estimate, Staar Surgical Co’s year-ago sales were $48.95MFor the next quarter, 6 analysts are estimating revenue of $71.98M. There is a high estimate of $79.1M for the next quarter, whereas the lowest estimate is $60.7M.
A total of 7 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $259.9M, while the lowest revenue estimate was $254.6M, resulting in an average revenue estimate of $257.23M. In the same quarter a year ago, actual revenue was $313.9MBased on 10 analysts’ estimates, the company’s revenue will be $314.5M in the next fiscal year. The high estimate is $344.5M and the low estimate is $271M.
